What Strainprint Technologies does

Strainprint Technologies Ltd. is a Toronto-based cannabis data and analytics company founded in 2016. Its core offering is a patient-facing mobile app (iOS and Android) that enables medical cannabis users to log sessions — capturing symptom, strain, ingestion method, and dosage — and earn loyalty rewards through the Strainpoints program. Aggregated, anonymized session data feeds a proprietary real-world evidence library covering more than 800,000 patient outcomes across 100+ symptoms and hundreds of cannabis strains, stored in Canada under HIPAA, PIPEDA and PHIPA compliant infrastructure.

The company monetizes this dataset primarily through an enterprise analytics platform sold on annual subscriptions to licensed producers, cannabis retailers, healthcare clinics, and government stakeholders (Health Canada is a named partner). A subscription research product, Strainprint Reports, provides analyst reports and custom research for medical cannabis practitioners and product formulators, while a white-label/OEM track has produced the myTrek app deployed with Australian partner Cannatrek. Customer logos include Aurora Cannabis, Tilray, Tikun Olam, WeedMD, 48North, MÜV, LYTE Clinics, GrowWise Health, VerdePharmHealth, and Bayer, with Surterra Wellness representing its first U.S. account.

The company was self-funded by a USD $3 million Series A in May 2018 led by Cesare Fazari of Molecular Science Corp and has not disclosed subsequent priced financing. Leadership comprises founder Stephanie Karasick, CEO Andrew Muroff, and President/CTO David Berg, with a medical advisory board that includes Drs. Caroline MacCallum, Danial Schecter, and Dean Elterman. The company operates from Toronto, Canada, with a headcount in the 11–50 range.

Name

Strainprint Technologies

Legal name

Strainprint Technologies Ltd.

Website

https://strainprint.ca

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Strainprint Technologies is a Toronto-based cannabis data and analytics company that runs a patient mobile app for tracking medical cannabis sessions and sells enterprise analytics, research reports, and white-label deployments to licensed producers, clinics, and government health authorities.

Ownership category

akta.pro rank

Product category

Medical Cannabis Data & Analytics

NAICS

Testing Laboratories and Services (54138)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics) (CRANAGAF)

Keywords

• Cannabis patient tracking
• Medical cannabis analytics
• Real-world evidence platform
• Cannabis data analytics
• Patient outcomes research

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Enterprise Analytics Subscriptions: Subscription-based analytics platform licenses to licensed producers, retailers, and healthcare clinics for access to real-time patient data, treatment efficacy insights, and industry benchmarking.
2. Research Reports: Sale of comprehensive research reports and custom research to medical cannabis practitioners, product formulators, and industry stakeholders seeking evidence-based insights.
3. Patient App (Freemium): Free mobile application for patients with loyalty rewards (Strainpoints) earned through session tracking, driving data collection while monetizing through enterprise subscriber access to aggregated insights.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Strainprint operates a patient-facing mobile cannabis tracking application (iOS/Android) that lets medical cannabis patients log sessions, symptoms, strains, ingestion methods and dosages to optimize treatment, paired with a subscription analytics platform that sells aggregated, anonymized real-world patient outcomes data, research study monitoring, and custom research reports to licensed cannabis producers, retailers, healthcare clinics, and researchers.

Product overview

Strainprint Technologies operates as a unified platform-plus-modules architecture, anchored by the Strainprint Mobile App for patient-side session tracking and the Strainprint Analytics platform for enterprise data access. The product portfolio extends through the Strainprint Reports subscription service, the Strainprint Community online forum, the Strainpoints™ loyalty program, and StrainSheets® educational content. A white-label variant (myTrek App) is distributed through the Cannatrek partnership. The core value proposition ties patient tracking data into aggregated analytics that feed reports and research insights, with loyalty rewards incentivizing sustained data contribution.

Differentiator

Problem solved

Functional benefit

Products and services

• Strainprint Mobile App Patient-facing mobile cannabis tracking application (iOS/Android) that allows medical cannabis patients to log sessions, symptoms, strains, ingestion methods, and dosages, view efficacy history, and earn Strainpoints loyalty rewards for data contribution.
• Strainprint Analytics Subscription-based business intelligence and analytics platform that provides subscribers with real-time patient usage data, treatment efficacy analysis, industry trend monitoring, and research study performance dashboards. Sold to licensed cannabis producers, retailers, and healthcare clinics on annual enterprise subscriptions.
• Strainprint Reports Subscription and custom research report product offering comprehensive analyst reports on Canadian medical cannabis experience, polypharmacy trends, and bespoke research for medical cannabis practitioners, product formulators, and industry stakeholders.
• myTrek App (White-label OEM) White-label version of Strainprint tracking technology deployed exclusively for Cannatrek patients to monitor health and safety and deliver personalized treatment recommendations.

Quantifiable outcome

• 47.3% reduction in headache severity reported in WSU study using Strainprint data
• +3 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Twelve partnerships are on record, tiered flagship, core, strategic and minor.

• Aurora CannabisflagshipStrategic or Co-development Partner · 26 April 2023Aurora Cannabis partnered with Strainprint in April 2023 to launch a new tracking program designed to support and empower cannabis patients on their wellness journey. The partnership enables Aurora to offer Strainprint's tracking capabilities to their patient base.
• Tilray MedicalcoreStrategic or Co-development Partner · 25 August 2022Tilray Medical partnered with Strainprint for the CannaPoints program supporting medical cannabis patients across Canada. Integration provides tracking capabilities alongside Tilray's product offerings.
• TruTrace TechnologiescoreTechnology or Integration · 7 May 2019Strategic working relationship to integrate Strainprint's patient data with TruTrace's StrainSecure traceability platform. Companies entered LOI for joint venture to develop tools improving cannabis patient experience through combined data and traceability.
• CannatrekflagshipOEM/ Whitelabel/ Licensing PartnerExclusive partnership to launch myTrek tracking app for Cannatrek patients. The app helps Cannatrek monitor customer health and safety and deliver treatment recommendations, enabling more confident production of suitable strains.
• VerdePharmHealthcoreStrategic or Co-development PartnerPartnership to provide technology supporting transformation of physician practices toward improved decision-support for medical cannabis interventions, coupled with patient-reported outcomes. Aimed at serving patients nationwide.
• GynicastrategicStrategic or Co-development PartnerInternational clinical trial partnership to establish world's first and largest database of medical cannabis effects on women. Partnership with Gynica and Lumir Lab focuses on treating endometriosis symptoms.
• Lumir LabstrategicStrategic or Co-development PartnerClinical trial partnership for monitoring real-time cannabis treatment for endometriosis symptoms. Leverages Strainprint's comprehensive research platform.
• Surterra WellnesscoreStrategic or Co-development PartnerFirst U.S. customer to Strainprint's comprehensive cannabis intelligence platform. Surterra gained access to Strainprint's data and analytics capabilities for their U.S. patient base.
• WeedMDcoreStrategic or Co-development PartnerWeedMD subscribed to Strainprint's data and analytics platform to gain key insights into consumer preferences for developing optimal cannabis products.
• MaRsminorOthersAffiliation with MaRs, an organization helping companies bring breakthrough ideas to market and scale globally.
• Global Cannabis PartnershipminorOthersActive member of the Global Cannabis Partnership, a collaboration of leaders in government-sanctioned adult-use recreational cannabis industry adhering to Responsible Cannabis Framework.
• Tikun OlamcoreStrategic or Co-development PartnerGlobal cannabis pioneer gained access to broad spectrum of Strainprint's product suite for medical cannabis treatment support and product optimization.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BDSA (formerly BDS Analytics): BDSA is a cannabis market intelligence and data analytics firm producing syndicated research, consumer insights, and sales tracking for the global cannabis industry. It directly competes with Strainprint Reports and analytics subscriptions targeting the same LP, CPG, and investor customer base.
• Headset: Headset is a cannabis retail and consumer data analytics platform serving dispensaries, brands, and distributors with point-of-sale integrations and market intelligence. It is the closest direct peer to Strainprint's enterprise analytics offering, though it is more retail/point-of-sale focused whereas Strainprint is patient-outcome focused.
• New Frontier Data: New Frontier Data provides cannabis industry data, market sizing, and consumer research reports, including the Cannabis Industry Annual Report. It competes with Strainprint Reports for the same enterprise insights buyers.

Broad incumbents

• Leafly: Leafly is the largest cannabis strain and product discovery platform with deep consumer engagement data and a B2B advertising/data arm. It is a broader incumbent in cannabis data and strain information, with overlapping use cases to Strainprint's symptom-strain matching and product database.
• Weedmaps: Weedmaps is a leading cannabis marketplace and SaaS provider (WM Technology) with retailer, brand, and consumer data assets. As a broader incumbent, it competes for the same enterprise wallet and offers adjacent data products to Strainprint's analytics.
• Akerna (acquired by Acuant, now Navigategate): Akerna (formerly MJ Freeway) provides cannabis seed-to-sale compliance, ERP, and analytics software to operators and regulators. It is a broader incumbent in cannabis enterprise software and data, competing for a portion of Strainprint's analytics budget.

Emerging players

• Springbig: Springbig is a cannabis loyalty, CRM, and marketing automation platform used by dispensaries and brands. It is an emerging SaaS peer in the cannabis retail/patient engagement space, overlapping with Strainprint's patient tracking and Strainpoints loyalty features.
• Jointly: Jointly is a cannabis wellness app that helps consumers track sessions, set intentions, and match products to effects. It is an emerging player in cannabis consumer tracking with significant overlap to Strainprint's patient app and data collection.
• Cannametrics: Cannametrics provides cannabis consumer and market analytics for retailers, brands, and LPs with panel-based insights and point-of-sale integrations. It is an emerging analytics peer competing for a portion of Strainprint's enterprise intelligence and reports business.

Regional players

• Cannvas MedTech: Cannvas MedTech is a Canadian cannabis education and data company offering a patient-facing platform with health assessment and learning tools. It is a regional peer operating in the same Canadian medical cannabis market with overlapping patient education and data themes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/strainprint
• Instagraminstagram.com/strainprint

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strainprint Technologies